Product Program year 2024 Source: CMS Open Payments

Pregabalin

Drug Neurology

NDC 43598-291-90

Open in the dashboard

General payments

$123,500

2 payments

Research payments

$133,000

2 payments

Through program year 2024, $123,500 in general payments and $133,000 in research payments were reported against Pregabalin (Neurology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2024 Research $133,000 2
2022 General $66,500 1
2021 General $57,000 1

Breakdown

Who paid General payments · program years 2021–2022
  1. Dr.Reddy's Laboratories,Inc. $123,500 2 payments

Prescribed to Medicare patients

Part D · data year 2024

Part D claims

6,821,045

Prescriptions dispensed, refills included

Drug cost

$196,545,996

Paid at the pharmacy, in all

Medicare Part D drugs matched to Pregabalin, 2024
Part D drug Name match Relative to the largest Prescribers Claims Drug cost
Pregabalin Same name 146,180 6,797,044 $179,375,580
Lyrica Pregabalin Same name 1,589 22,313 $16,708,738
Pregabalin Er Pregabalin Same name 106 1,617 $388,700
Lyrica Cr Pregabalin Same name 6 71 $72,978

Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.

Largest prescribers

First 5 of 301 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Jacob Vella Interventional Pain Management AL 2,515 $41,119 None on record
David Mulkey Family Practice AL 2,268 $49,235 None on record
Aaron Shinkle Anesthesiology AL 2,068 $46,528 None on record
Maheep Birdi Neurology CA 1,869 $49,132 None on record
Joseph Essmyer Anesthesiology MO 1,838 $38,306 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 301 with Patron
2 general · 2 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record